S-Bank Fund Management’s West Pharmaceutical WST Stock Holding History

S-Bank Fund Management’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$342K	Sell	952 -1,189	-56%	-$364K	0.05%	193
2026 Q1	$537K	Sell	2,141 -80	-4%	-$19.9K	0.08%	118
2025 Q4	$611K	Sell	2,221 -75	-3%	-$20.5K	0.08%	109
2025 Q3	$602K	Sell	2,296 -30	-1%	-$7.29K	0.08%	131
2025 Q2	$509K	Sell	2,326 -202	-8%	-$43.2K	0.08%	146
2025 Q1	$566K	Buy	+2,528	New	+$697K	0.11%	113

Other funds holding WST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

S-Bank Fund Management's WST Position: Q2 2026 in Review

S-Bank Fund Management reduced its West Pharmaceutical (WST) stake by 56% in Q2 2026, selling an estimated $364K and leaving 952 shares worth $342K. The position accounts for 0.05% of the portfolio, ranked #193.

S-Bank Fund Management first reported a position in WST in Q1 2025 and has held it in 6 quarters since. The position peaked at $611K in Q4 2025. 834 funds tracked by Wall St. Rank hold WST as of Q2 2026.

S-Bank Fund Management held 952 shares of West Pharmaceutical worth $342K as of Q2 2026.
S-Bank Fund Management sold 1,189 West Pharmaceutical shares in Q2 2026, an estimated $364K.
West Pharmaceutical made up 0.05% of S-Bank Fund Management's portfolio in Q2 2026, its #193 holding.
S-Bank Fund Management first reported a position in West Pharmaceutical in Q1 2025 and has held it in 6 quarters since.
S-Bank Fund Management's West Pharmaceutical position peaked at $611K in Q4 2025.
834 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on S-Bank Fund Management's 13F filing for Q2 2026, filed 4 Aug 2026.